Patients with atypical odontalgia (AO) complain of medically unexplained toothache. No evidence-based diagnostic criteria or treatment guidelines are yet available. The present paper addresses seven clinical questions about AO based on current knowledge in the literature and discusses diagnostic criteria and guidelines for treatment and management. The questions are (i) What is the prevalence of AO in the community? (ii) What psychological problems are experienced by patients with AO? (iii) Are there any comorbidities of AO? (iv) Is local anesthesia effective for the relief of pain in AO? (v) Are there any characteristic symptoms of AO other than spontaneous pain? (vi) Are antidepressants effective for treatment of AO? (vii) Are anticonvulsants effective for treatment of AO? Our literature search provided answers for these questions; however, there is insufficient evidence-based data to establish guidelines for the diagnosis and treatment of AO. Overall, some diagnostic criteria for neuropathic pain and persistent dentoalveolar pain disorder may be applied to AO patients. The patient's psychogenic background should always be considered in the treatment and/or management of AO. The clinicians may need to treat AO patients using Patient-Oriented Evidence that Matters approach.
1. Introduction
Patients with atypical odontalgia (AO) complain of medically unexplained toothache. Symptoms include pain without any pathological changes and/or stronger pain than would be expected from the clinical findings. AO is a subgroup of persistent idiopathic facial pain disorder as defined by the International Headache Society [1]. Any dental procedures including scaling, restorative treatment, and endodontic treatment pose potential risk of AO. In many cases, the persistent nature of the pain prompts dentists to treat the teeth in the absence of any pathological findings. The treatment often exacerbates the pain instead of relieving it. Dentists usually consider a diagnosis of AO only after the failure of invasive treatment. Although it is crucial to establish diagnostic criteria for AO, the evidence-based literature to date has been insufficient to make this possible.
Several clinical management methods for AO have been reported [2–11]. The pathophysiological mechanism of AO may provide useful information for effective management. Possible pathophysiological mechanisms for AO include those with neuropathic, vascular, and psychogenic origins. Since the clinical course of AO varies among patients, and each case may stem from a different origin, a universal treatment method may not be effective for all AO patients, and it may be difficult to establish an evidence base for clinical management.
We formulated seven questions based on our clinical experience in the Japanese Society of Psychosomatic Dentistry. The questions are
What is the prevalence of AO in the community?
What psychological problems are experienced by patients with AO?
Are there any comorbidities of AO?
Is local anesthesia effective for the relief of pain in AO?
Are there any characteristic symptoms of AO other than spontaneous pain?
Are antidepressants effective for treatment of AO?
Are anticonvulsants effective for treatment of AO?
These questions will be reviewed based on current knowledge in the literature, and diagnostic criteria and guidelines for treatment and management will be discussed.
2. What Is the Prevalence of AO in the Community?
AO was found in 2.1% of a population of 3000 at the University of Southern California Orofacial Pain and Oral Medicine Center [12]. Other studies suggest that AO occurs in 3–6% of patients undergoing endodontic treatment [2, 13–17]. Polycarpou et al. [18] examined 175 patients at the Eastman Dental Hospital, a secondary healthcare facility, and found the prevalence of persistent pain after successful root canal treatments was 12%. They determined that significant risk factors leading to the development of chronic pain after endodontic treatment were the presence and duration of preoperative pain from the tooth, tenderness to percussion of the tooth preoperatively, female gender, previous painful treatment in the orofacial region, previous chronic pain problems, and whether surgical treatment was received. It is generally agreed that AO occurs more frequently in females than in males; 80–90% of all cases are female [7, 19–23]. Complaints were predominantly reported in the upper jaw (ratio 8 : 2) with the majority in the molar region (ratio 5 : 3) [20]. List et al. [24] reported in a study of 46 cases of AO that 56% of patients complained of pain in the upper jaw, compared with 45% in the lower jaw (one patient had pain in both jaws). These frequencies are useful for diagnosing AO after successful root canal treatment.
3. What Psychological Problems Are Experienced by Patients with AO?
Psychogenic pain is caused, increased, or prolonged by mental, emotional, or behavioral factors [25]. In addition to psychogenic pain, other pathophysiological mechanisms including neuropathic and vascular abnormalities have been linked with AO. Since the pain debut of 83% of AO patients was related to an invasive dental or surgical procedure [26], AO could be attributed to neuropathic pain caused by deafferentation [27–29]. However, pain in AO can also be spontaneous with no history of invasive dental or surgical procedures. Vascular pain has been proposed as a mechanism for AO, since AO patients occasionally suffer from migraine possibly caused by vascular events [30]. No scientific evidence has supported this hypothesis thus far [1, 31]. AO patients usually experience associated psychological problems such as depression, somatoform pain disorder, anxiety, demoralization, introversion, or hypochondriacal psychosis [6, 8, 21, 32–40]. AO patients may have a history of depression (66%) or depressive symptom (41%) [21, 41]. List et al. [26] examined 46 patients with AO and found significantly higher scores for depression and somatization in the AO group than the control group. Baad-Hansen et al. [42] found that mean depression and somatization scores were moderate to high in 46 patients with AO. These studies support a strong correlation between AO and psychological conditions. These psychological problems, however, may not reflect psychiatric diagnoses of AO. Takenoshita et al. [43] investigated 37 AO patients referred from psychiatric facilities to dental clinics and found that 33.3% of the patients had no specific psychiatric diagnosis. It is not known whether AO patients with no specific psychiatric conditions experience neuropathic and/or vascular pain. The psychiatric or psychological approach is generally effective but may not be absolutely essential for AO patients.
There is some argument as to whether psychological problems are the primary or secondary cause of AO [15, 42]. Graff-Radford [44] suggested that depression was not the cause of AO, and Brooke and Merskey [45] hypothesized that depression was not the sole cause of AO. These reports suggest that psychological factors are not significant in the genesis of AO [15]. Whether psychological problems are primary or secondary causes of AO, the psychological background of the patient should always be considered, given the high incidence of psychological problems in AO patients.
4. Are There Any Comorbidities of AO?
AO may share pain mechanisms with other chronic orofacial pain conditions, such as atypical facial pain and temporomandibular disorder (TMD). Baad-Hansen et al. [42] examined 46 AO patients and showed that episodic tension-type headache (TTH), chronic TTH, and myofascial temporomandibular disorder occurred in 46%, 18%, and 50% of AO patients, respectively. Other researchers reported that TMD pain, TTH, and widespread pain were significantly more common among AO patients than controls [26]. In addition to being linked with TMD or TTH, AO has been reported in patients with burning mouth syndrome (BMS) [11, 46–48]. However, no statistical data to date has established the frequency of the comorbidity of AO with BMS. TMD should be considered as a comorbid disorder for AO.
5. Is Local Anesthesia Effective for the Relief of Pain in AO?
Several investigators have studied the use of local anesthesia to relieve the pain of OA. Vickers et al. [10] reported a significant reduction in pain in a group of AO patients treated with local anesthesia. A randomized controlled trial undertaken by List et al. [5] corroborated the evidence of this paper. List et al. [5] evaluated the analgesic effect of local anesthesia (lidocaine) in a randomized controlled trial on 35 consecutive AO patients. They concluded that AO patients experienced significant, but not complete, pain relief from administration of local anesthetics compared with placebo. The pain relief was transient and was only at 15–120 min following the administration of the local anesthetics. In contrast, Graff-Radford and Solberg [49] found no significant difference in pain relief in AO patients after administration of local anaesthetic, although patients with nociceptive pain significantly improved. Two other uncontrolled studies showed similar findings [19, 21]. The clinical course of AO patients varies, and the effectiveness of local anesthesia may depend on the type of pathophysiological mechanisms of AO. Lidocaine patches were found to be clearly effective in reducing ongoing pain and allodynia in peripheral neuropathic pain syndrome [50]. Local anesthesia may transiently relieve pain in AO patients whose pain stems from neuropathic sources. Further investigations are needed to clarify this hypothesis.
6. Are There Any Characteristic Symptoms of AO Other Than Spontaneous Pain?
The persistent pain in AO can be altered by various stimuli. The sensations of 10 AO patients were compared with 10 matched healthy controls. The AO patients showed increased sensitivity to capsaicin and heat pain, but no significant differences in cold and mechanical sensitivity [13]. A study by Zagury et al. [51] comparing 21 AO patients with 18 controls found that the duration of pain sensation on cold application was significantly longer in AO patients, although the level of pain to cold stimulus was not statistically different between the AO and control group. List et al. [24] observed significant abnormalities in intraoral somatosensory function in AO patients, which may reflect peripheral and central sensitization of trigeminal pathways.
7. Are Antidepressants Effective for Treatment of AO?
A meta-analysis of available data revealed that in patients diagnosed with psychogenic pain or somatoform pain disorder, antidepressant treatment resulted in a reduction in pain that was significantly greater than that of placebo [52]. Tricyclic antidepressants (TCAs) are the standard treatment choice for psychogenic pain or somatoform pain disorder. In the management of AO, TCAs have usually been prescribed alone or in combination with phenothiazines [2–4, 6–9, 11, 53, 54] (Figure 1). Adverse effects should be considered when prescribing both TCAs and phenothiazines. Phenothiazines have been linked with potentially irreversible adverse effects in the nervous system causing tardive dyskinesia. A literature review by Baad-Hansen et al. [42] noted that there is a need for a high-quality randomized controlled trial in AO patients to evaluate the effect of TCAs on AO pain. A recent study by Ito et al. [55] evaluated the effectiveness of milnacipran for pain relief in 36 patients with chronic pain in the orofacial region and a diagnosis of AO or burning mouth syndrome. They found that the visual analog scale score decreased significantly after treatment in comparison with the baseline score. To our knowledge, this is the only study to use milnacipran in the treatment of AO, although the effectiveness of milnacipran on other pain disorders has been established [56–62]. High-quality clinical research such as a randomized controlled trial should be performed to assess the effectiveness of milnacipran in the treatment of AO.
Panoramic radiograph shows a case of atypical odontalgia causing in a 57-year-old woman. The woman complained of toothache in the bilateral upper molars after the replacement of dental implant into the lower jaws. The root canal treatments of upper molars were performed, and the upper molars were finally extracted, since her pain was not relived by any treatments. A prescription of 40 mg per a day of amitriptyline decreased symptoms in the patient.
8. Are Anticonvulsants Effective for Treatment of AO?
Anticonvulsants have been recommended for the management of AO and orofacial pain by several authors [63–65]. Recently, a systematic review on the effectiveness of anticonvulsants for the management of orofacial pain was conducted using randomized controlled trials [66]. According to this paper, gabapentin [67], topical clonazepam [68], lamotrigine [69], and carbamazepine [70, 71] reduce the pain intensity significantly in patients with chronic masticatory myalgia, stomatodynia, refractory trigeminal neuralgia, and trigeminal neuralgia, respectively. There is, however, limited to moderate evidence supporting the efficacy of the anticonvulsants for treatment of patients with orofacial pain disorder. More randomized controlled trials were needed to confirm the effectiveness [66]. Although AO is a type of oral facial pain disorder, there is less evidence supporting their effectiveness for AO. According to a paper reviewed by Matwychuk [72], the anticonvulsants can be used as a treatment and diagnostic tool for trigeminal neuralgia, whereas antidepressants have been reported to show good results for atypical odontalgia. Anticonvulsants may be less effective for AO than antidepressants. Further investigation is needed to clarify this hypothesis.
9. Conclusion
There is insufficient evidence-based data available to establish guidelines for the diagnosis and treatment of AO thus far. Several diagnostic criteria for AO have been proposed [1, 6, 8, 9, 49]. Common findings in the criteria are “Pain is described as a toothache” and “No radiographic or laboratory investigations demonstrate relevant abnormality.” Many other findings are shown in the criteria, but may not be essential for diagnosis. The present clinical questions addressing prevalence, comorbid diseases, and the characteristics of the pain may be useful for the establishment of diagnostic criteria. Further investigations are needed to consolidate the evidence base.
Evidence-based data are also needed to establish guidelines for treatment and management of AO. Precise pathophysiological information about the underlying mechanisms involved in AO is needed to provide an effective strategy for treatment or management of AO. As mentioned above, the three main hypotheses about the pathophysiology of AO relate to whether the condition has a psychogenic, vascular or neuropathic derivation. Diagnostic criteria of defined neuropathic pain [73] and a treatment algorithm for neuropathic pain based on evidence-based research [74] are available. These criteria and the algorithm could be applied to AO patients whose pain can be attributed to neuropathic factors. Such patients may be identified by the fact that local anesthesia results in pain relief. Meier et al. [50] proposed that neuropathic mechanisms are the primary cause of AO pain, and that psychological disturbances are probably more a consequence than the cause of chronic pain. Recently, diagnostic criteria for persistent dentoalveolar pain disorder were proposed by International RDC-TMD Consortium [75]. These criteria may be adaptive for AO. Since there is a general consensus about the involvement of psychological problems as either a primary or secondary cause of AO, patients cannot be treated as if the pain is of neuropathic origin only. The patient’s psychogenic background should always be considered in the treatment and/or management of AO. In the present paper, we attempted to use the most reliable evidence-based data. Recently, Patient-Oriented Evidence that Matters (POEM) is emerging as a more significant approach than evidence-based data for use in clinical practice [76, 77]. Given that in psychosomatic diseases, doctor-centered interventions, and close observation of the doctor-patient relationship are of particular importance [78], clinicians may need to treat AO patients using the POEM approach.
Headache Classification Committee of the International Headache SocietyClassification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain198887196CampbellR. L.ParksK. W.DoddsR. N.Chronic facial pain associated with endodontic therapy19906932872902-s2.0-0025308121FeinmannC.Newton-JohnT.Psychiatric and psychological management considerations associated with nerve damage and neuropathic trigeminal pain20041843603652-s2.0-8844286129KaspoG. A.Atypical odontalgia in the dental office199577534362-s2.0-17644448412ListT.LeijonG.HelkimoM.ÖsterA.SvenssonP.Effect of local anesthesia on atypical odontalgia—a randomized controlled trial200612233063142-s2.0-3364656995910.1016/j.pain.2006.02.005MarbachJ. J.Is phantom tooth pain a deafferentation (neuropathic) syndrome? Part I: evidence derived from pathophysiology and treatment1993751951052-s2.0-002752289910.1016/0030-4220(93)90413-XMarbachJ. J.Phantom tooth pain19784123623722-s2.0-001811195110.1016/S0099-2399(78)80211-8MarbachJ. J.RaphaelK. G.Phantom tooth pain: a new look at an old dilemma20001168772-s2.0-0345982573PertesR. A.BaileyD. R.MiloneA. S.Atypical odontalgia—a nondental toothache199566129332-s2.0-0029418164VickersE. R.CousinsM. J.WalkerS.ChisholmK.Analysis of 50 patients with atypical odontalgia: a preliminary report on pharmacological procedures for diagnosis and treatment199885124322-s2.0-0031612184WodaA.PionchonP.A unified concept of idiopathic orofacial pain: clinical features19991321721842-s2.0-0346613556RamS.TeruelA.KumarS. K. S.ClarkG.Clinical characteristics and diagnosis of atypical odontalgia: implications for dentists200914022232282-s2.0-60449116929Baad-HansenL.JuhlG. I.JensenT. S.BrandsborgB.SvenssonP.Differential effect of intravenous S-ketamine and fentanyl on atypical odontalgia and capsaicin-evoked pain20071291-246542-s2.0-3404725850110.1016/j.pain.2006.09.032MarbachJ. J.HulbrockJ.HohnC.SegalA. G.Incidence of phantom tooth pain: an atypical facial neuralgia19825321901932-s2.0-0020472921MelisM.LoboS. L.CenevizC.ZawawiK.Al-BadawiE.MaloneyG.MehtaN.Atypical odontalgia: a review of the literature20034310106010742-s2.0-034738113010.1046/j.1526-4610.2003.03207.xNixdorfD. R.Moana-FilhoE. J.LawA. S.McGuireL. A.HodgesJ. S.JohnM. T.Frequency of persistent tooth pain after root canal therapy: a systematic review and meta-analysis20103622242302-s2.0-7454912613210.1016/j.joen.2009.11.007NixdorfD. R.Moana-FilhoE. J.LawA. S.McGuireL. A.HodgesJ. S.JohnM. T.Frequency of nonodontogenic pain after endodontic therapy: a systematic review and meta-analysis2010369149414982-s2.0-7804937412810.1016/j.joen.2010.06.020PolycarpouN.NgY. L.CanavanD.MolesD. R.GulabivalaK.Prevalence of persistent pain after endodontic treatment and factors affecting its occurrence in cases with complete radiographic healing20053831691782-s2.0-1574437099310.1111/j.1365-2591.2004.00923.xBatesR. E.Jr.StewartC. M.Atypical odontalgia: phantom tooth pain19917244794832-s2.0-0025998887JacobsR.WuC. H.GoossensK.de LaatA.van LovenK.AntonisY.LambrechtsP.van SteenbergheD.A case-control study on the psychophysical and psychological characteristics of the phantom tooth phenomenon20026158642-s2.0-0036512033ReesR. T.HarrisM.Atypical odontalgia19791632122182-s2.0-0018711157ReikL.Jr.Atypical odontalgia: a localized form of atypical facial pain19842442222242-s2.0-0021683202SchnurrR. F.BrookeR. I.Atypical odontalgia: update and comment on long-term follow-up19927344454482-s2.0-002658189010.1016/0030-4220(92)90322-HListT.LeijonG.SvenssonP.Somatosensory abnormalities in atypical odontalgia: a case-control study200813923333412-s2.0-5304909535110.1016/j.pain.2008.05.002GatchelR. J.PengY. B.PetersM. L.FuchsP. N.TurkD. C.The biopsychosocial approach to chronic pain: scientific advances and future directions200713345816242-s2.0-3454853595410.1037/0033-2909.133.4.581ListT.LeijonG.HelkimoM.ÖsterA.DworkinS. F.SvenssonP.Clinical findings and psychosocial factors in patients with atypical odontalgia: a case-control study200721289982-s2.0-34249083247BlasbergB.ChalmersA.Temporomandibular pain and dysfunction syndrome associated with generalized musculoskeletal pain: a retrospective study1989161987902-s2.0-0024760731HagbergC.General musculoskeletal complaints in a group of patients with craniomandibular disorders (CMD). A case control study19911541791852-s2.0-0026041458TürpJ. C.KowalskiC. J.O'LearyN.StohlerC. S.Pain maps from facial pain patients indicate a broad pain geography1998776146514722-s2.0-0032223639WodaA.Tubert-JeanninS.BouhassiraD.AttalN.FleiterB.GouletJ. P.Gremeau-RichardC.Louise NavezM.PicardP.PionchonP.AlbuissonE.Towards a new taxonomy of idiopathic orofacial pain200511633964062-s2.0-2184446134410.1016/j.pain.2005.05.009GalerB. S.JensenM. P.Development and preliminary validation of a pain measure specific to neuropathic pain: the neuropathic pain scale19974823323382-s2.0-0031030523BrookeR. I.Atypical odontalgia. A report of twenty-two cases19804931961992-s2.0-0018856646KlausnerJ. J.Epidemiology of chronic facial pain: diagnostic usefulness in patient care199412512160416112-s2.0-0028712207KreisbergM. K.Atypical odontalgia: differential diagnosis and treatment198210468528542-s2.0-0020146748LascellesR. G.Atypical facial pain and depression19661124886516592-s2.0-0013923847MarbachJ. J.Is phantom tooth pain a deafferentation (neuropathic) syndrome? Part II: psychosocial considerations19937522252322-s2.0-0027469515MarbachJ. J.Phantom tooth pain: differential diagnosis and treatment1993591028332-s2.0-0027720385BogdukN.MerskeyH.19942ndSeattle, Wash, USAIASP PressPöllmannL.Determining factors of the phantom tooth1993591042452-s2.0-0027712582RemickR. A.BlasbergB.BartonJ. S.CamposP. E.MilesJ. E.Ineffective dental and surgical treatment associated with atypical facial pain19835543553582-s2.0-0020525255BrookeR. I.SchnurrR. F.Diagnosing and treating atypical odontalgia199544130322-s2.0-0029418386Baad-HansenL.LeijonG.SvenssonP.ListT.Comparison of clinical findings and psychosocial factors in patients with atypical odontalgia and temporomandibular disorders20082217142-s2.0-39449139321TakenoshitaM.SatoT.KatoY.Psychiatric diagnoses in patients with burning mouth syndrome and atypical odontalgia referred from psychiatric to dental facilities20106699705Graff-RadfordS. B.1999Seattle, Wash, USAIASP PressBrookeR. I.MerskeyH.Is atypical odontalgia a psychological problem?1994771232-s2.0-0028120243DubnerR.GoldM.The neurobiology of pain19999614762776302-s2.0-003352927610.1073/pnas.96.14.7627GrushkaM.EpsteinJ. B.GorskyM.Burning mouth syndrome and other oral sensory disorders: a unifying hypothesis2003831331352-s2.0-0345330890OkesonJ. P.The American Academy of Orofacial Pain1991Chicago, Ill, USAQuintessenceGraff-RadfordS. B.SolbergW. K.Atypical odontalgia1992642602652-s2.0-0026922110MeierT.WasnerG.FaustM.KuntzerT.OchsnerF.HueppeM.BogousslavskyJ.BaronR.Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study20031061-21511582-s2.0-014219607310.1016/S0304-3959(03)00317-8ZaguryJ. G.EliavE.HeirG. M.Nasri-HeirC.AnanthanS.PertesR.SharavY.BenolielR.Prolonged gingival cold allodynia: a novel finding in patients with atypical odontalgia201111133123192-s2.0-7995150904610.1016/j.tripleo.2010.10.008FishbainD. A.CutlerR. B.RosomoffH. L.RosomoffR. S.Do antidepressants have an analgesic effect in psychogenic pain and somatoform pain disorder? A meta-analysis19986045035092-s2.0-0031904295ShermanJ. J.LeRescheL.HugginsK. H.ManclL. A.SageJ. C.DworkinS. F.The relationship of somatization and depression to experimental pain response in women with temporomandibular disorders20046668528602-s2.0-924426243310.1097/01.psy.0000140006.48316.80SvenssonP.Arendt-NielsonL.Clinical and experimental aspects of temporomandibular disorders2000421581652-s2.0-0034565384ItoM.KimuraH.YoshidaK.KimuraY.OzakiN.KuritaK.Effectiveness of milnacipran for the treatment of chronic pain in the orofacial region201033279832-s2.0-7795103256110.1097/WNF.0b013e3181cb5793GendreauR. M.ThornM. D.GendreauJ. F.KranzlerJ. D.RibeiroS.GracelyR. H.WilliamsD. A.MeaseP. J.McLeanS.ClauwD. J.Efficacy of milnacipran in patients with fibromyalgia20053210197519852-s2.0-26444518188ItoM.YoshidaK.KimuraH.OzakiN.KuritaK.Successful treatment of trigeminal neuralgia with milnacipran20073031831852-s2.0-3424987926410.1097/wnf.0b013e31803bb3daKamataM.TakahashiH.NaitoS.HiguchiH.Effectiveness of milnacipran for the treatment of chronic pain: a case series20042752082102-s2.0-744424793610.1097/01.wnf.0000145507.07261.a6ShimamotoE.DoiN.SuwaH.ShibuiF.IshimaruK.FukubayashiN.A case of postherpetic neuralgia improved by milnacipran20025197200ToyofukuA.Efficacy of milnacipran for glossodynia patients20037123242-s2.0-004276905510.1080/13651500310000861UtunomiyaK.UkitaT.HiritaS.One case of postherpetic neuralgia treated with milnacipran20025193196VittonO.GendreauM.GendreauJ.KranzlerJ.RaoS. G.A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia2004191S27S352-s2.0-634423125810.1002/hup.622SaxenM. A.Myofascial pain syndrome: characteristics, diagnosis, and treatment19987739122-s2.0-0032151371VickersE. R.CousinsM. J.Neuropathic orofacial pain part 1—prevalence and pathophysiology200026119262-s2.0-0034172963VickersE. R.CousinsM. J.Neuropathic orofacial pain. Part 2-diagnostic procedures, treatment guidelines and case reports200026253632-s2.0-0034252663MartinW. J. J. M.ForouzanfarT.The efficacy of anticonvulsants on orofacial pain: a systematic review201111156276332-s2.0-7995460503210.1016/j.tripleo.2011.01.033KimosP.BiggsC.MahJ.HeoG.RashiqS.ThieN. M. R.MajorP. W.Analgesic action of gabapentin on chronic pain in the masticatory muscles: a randomized controlled trial20071271-21511602-s2.0-3384574335310.1016/j.pain.2006.08.028Gremeau-RichardC.WodaA.NavezM. L.AttalN.BouhassiraD.GagnieuM. C.LaluqueJ. F.PicardP.PionchonP.TubertS.Topical clonazepam in stomatodynia: a randomised placebo-controlled study20041081-251572-s2.0-1074423392310.1016/j.pain.2003.12.002ZakrzewskaJ. M.ChaudhryZ.NurmikkoT. J.PattonD. W.MullensE. L.Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial19977322232302-s2.0-003081018910.1016/S0304-3959(97)00104-8KillianJ. M.FrommG. H.Carbamazepine in the treatment of neuralgia. Use of side effects19681921291362-s2.0-0014322229NicolC. F.A four year double-blind study of tegretol in facial pain19699154572-s2.0-0014503220MatwychukM. J.Diagnostic challenges of neuropathic tooth pain20047085425462-s2.0-23444461186KehletH.JensenT. S.WoolfC. J.Persistent postsurgical pain: risk factors and prevention20063679522161816252-s2.0-3364634470110.1016/S0140-6736(06)68700-XFinnerupN. B.OttoM.McQuayH. J.JensenT. S.SindrupS. H.Algorithm for neuropathic pain treatment: an evidence based proposal200511832893052-s2.0-2794446701310.1016/j.pain.2005.08.013NixdorfD. R.DrangsholtM. T.EttlinD. A.GaulC.de LeeuwR.SvenssonP.ZakrzewskaJ. M.de LaatA.CeustersW.Classifying orofacial pains: a new proposal of taxonomy based on ontology201239316116910.1111/j.1365-2842.2011.02247.xAssaelL. A.POEMs (patient-oriented evidence that matters): the surgeon's poetry20096711232123222-s2.0-7034984723610.1016/j.joms.2009.09.001ChiappelliF.CajulisO. S.Transitioning toward evidence-based research in the health sciences for the XXI century2008521231282-s2.0-4464913399210.1093/ecam/nem123HenningsenP.ZipfelS.HerzogW.Management of functional somatic syndromes200736995659469552-s2.0-3394714096910.1016/S0140-6736(07)60159-7